Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colon Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Prostate Cancer
• Renal Cell Carcinoma
• Upper Gi Tract Cancer

Drugs mentioned

• V934
• V935

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Non-Small Cell Lung Carcinoma, Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2014-06-03